Published on 28 May 2023 on Simply Wall St. via Yahoo Finance
Krishna Vaddi Buys Handful Of Shares In Prelude Therapeutics \
Whilst it may not be a huge deal, we thought it was good to see that the Prelude Therapeutics Incorporated (NASDAQ:PRLD) Founder, Krishna Vaddi, recently bought US$67k worth of stock, for US$5.63 per share. Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a good sign.
See our latest analysis for Prelude Therapeutics
The Last 12 Months Of Insider Transactions At Prelude Therapeutics